Want to see JMPLY full AI Analyst Report?
Johnson Matthey (JMPLY) AI Stock Analysis
Johnson Matthey
(Other OTC:JMPLY)
The score is held back primarily by weak financial performance—especially the swing to a net loss and margin compression—despite steady operating cash flow and positive free cash flow. Technicals are a supportive offset with the stock trading above key moving averages and a positive MACD, while valuation is mixed due to the negative P/E and a very high dividend yield that may carry sustainability risk.
Johnson Matthey (JMPLY) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $3.87B
- Dividend Yield
- 30.79%
- Average Volume (3M)
- 1,548
- Price to Earnings (P/E)
- -39.6
- Beta (1Y)
- 0.61
- Revenue Growth
- 13.14%
- EPS Growth
- -129.80%
- Country
- US
- Employees
- 9,500
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
Johnson Matthey Business Overview & Revenue Model
Company Description
Johnson Matthey Plc is a multinational company primarily engaged in clean air solutions, advanced catalyst and hydrogen technologies, and services related to platinum group metals (PGMs). Its extensive operations span the United Kingdom, continental...
How the Company Makes Money
Johnson Matthey makes money primarily by selling high-value catalyst products, licensing process technologies, and providing services linked to the sourcing, use, and recovery of precious/critical metals. Key revenue streams typically include: (1) Ca...
Johnson Matthey Financial Statement Overview
Summary
Mixed fundamentals: revenue rebounded in 2026 (+12.3% YoY) and operating cash flow was steady (~$382M) with positive free cash flow (~$162M). However, profitability deteriorated sharply with net income turning negative (-$98M) and meaningful margin compression (gross ~5.0% vs ~7.7%; EBITDA ~3.8% vs ~6.9%). Balance sheet leverage is manageable (debt-to-equity ~0.70) but declining equity and negative ROE (~-4.8%) raise earnings-risk concerns.
Income Statement
38NegativeBalance Sheet
56NeutralCash Flow
45Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.67B | 12.78B | 11.67B | 12.84B | 14.93B | 16.02B |
| Gross Profit | 633.03M | 639.23M | 899.00M | 898.00M | 989.00M | 1.05B |
| EBITDA | 477.91M | 486.79M | 802.00M | 488.00M | 621.00M | 467.00M |
| Net Income | -97.17M | -97.56M | 373.00M | 108.00M | 276.00M | -101.00M |
Balance Sheet | ||||||
| Total Assets | 5.97B | 5.97B | 6.19B | 6.34B | 7.03B | 6.67B |
| Cash, Cash Equivalents and Short-Term Investments | 590.03M | 590.03M | 898.00M | 542.00M | 697.00M | 418.00M |
| Total Debt | 1.41B | 1.41B | 1.70B | 1.49B | 1.67B | 1.25B |
| Total Liabilities | 3.96B | 3.96B | 3.90B | 3.96B | 4.49B | 4.22B |
| Stockholders Equity | 2.02B | 2.02B | 2.29B | 2.38B | 2.54B | 2.44B |
Cash Flow | ||||||
| Free Cash Flow | 161.25M | 161.59M | 8.00M | 224.00M | -91.00M | 73.00M |
| Operating Cash Flow | 379.31M | 382.11M | 381.00M | 592.00M | 225.00M | 526.00M |
| Investing Cash Flow | -282.57M | -285.57M | 297.00M | -255.00M | -129.00M | -292.00M |
| Financing Cash Flow | -444.69M | -451.22M | -333.00M | -439.00M | 191.00M | -439.00M |
Johnson Matthey Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JMPLY, the sentiment is Positive. The current price of 63.98 is below the 20-day moving average (MA) of 65.43, above the 50-day MA of 63.55, and above the 200-day MA of 59.40, indicating a neutral trend. The MACD of 0.58 indicates Positive momentum. The RSI at 45.65 is Neutral, neither overbought nor oversold. The STOCH value of 19.59 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JMPLY.
Johnson Matthey Peers Comparison
Overall Rating
LIN77Outperform
IOSP76Outperform
ECVT61Neutral
ALB58Neutral
NGVT58Neutral
JMPLY52Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | $236.08B | 34.01 | 18.05% | 1.23% | 8.16% | 0.67% | |
| 76Outperform | $2.46B | 20.34 | 9.15% | 1.79% | 2.87% | 534.76% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 61Neutral | $1.11B | -18.75 | -10.33% | ― | 20.14% | -359.78% | |
| 58Neutral | $10.74B | 189.58 | 2.26% | 1.79% | 18.32% | ― | |
| 58Neutral | $2.55B | 48.26 | 85.17% | ― | -12.42% | ― | |
| 52Neutral | $3.98B | -39.59 | -4.72% | 30.79% | 13.14% | -129.80% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JMPLY | Johnson Matthey | 63.98 | 7.00 | 12.28% | |
| ALB | Albemarle Corporation | 91.00 | -4.44 | -4.65% | |
| IOSP | Innospec | 99.89 | 27.13 | 37.28% | |
| NGVT | Ingevity | 74.32 | 20.48 | 38.04% | |
| ECVT | Ecovyst Inc | 10.12 | 1.85 | 22.37% | |
| LIN | Linde Plc | 514.24 | 107.58 | 26.45% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 18, 2026